Beverly A. Claiborne, Jr., appeals from the district courts order denying his motion for compassionate release. On appeal, he asserts that the district court erred by concluding that his hypertension was insufficiently serious to qualify as an extraordinary and compelling reason for release in the context of the COVID-19 pandemic and that the court overlooked evidence of Claibornes mitigating circumstances. We affirm.
The district court may reduce a term of imprisonment under 18 U.S.C. § 3582(c)(1)(A)(i), if “extraordinary and compelling reasons warrant such a reduction,” upon a motion by the Bureau of Prisons’ (BOP) Director or by the defendant after he has exhausted his administrative remedies with the BOP. 18 U.S.C. § 3582(c)(1)(A)(i). When deciding whether to reduce a defendants sentence under § 3582(c)(1)(A), a district court generally proceeds in three steps. See United States v. High, 997 F.3d 181, 185-86 (4th Cir. 2021). First, the court determines whether “extraordinary and compelling reasons” support a sentence reduction. 18 U.S.C. § 3582(c)(1)(A)(i); High, 997 F.3d at 186. “In the context of the COVID-19 outbreak, courts have found extraordinary and compelling reasons for compassionate release when an inmate shows both a particularized susceptibility to the disease and a particularized risk of contracting the disease at his prison facility.” United States v. Feiling, 453 F. Supp. 3d 832, 841 (E.D. Va. 2020) (citing cases). Next, the court considers whether “a [sentence] reduction is consistent with applicable policy statements issued by the Sentencing Commission.” 18 U.S.C. § 3582(c)(1)(A)(ii); High, 997 F.3d at 186. Finally, if the court finds that extraordinary and compelling reasons warrant relief, the court must consider the 18 U.S.C. § 3553(a) factors “in deciding whether to exercise its discretion to reduce the defendants term of imprisonment.” High, 997 F.3d at 186; 18 U.S.C. § 3582(c)(1)(A).
On appeal, Claiborne challenges the district courts conclusions on his particularized susceptibility to serious disease and the district courts consideration of the § 3553 factors. However, the district court also determined that Claiborne failed to show that he faced a particularized risk at Lee USP, given its low positivity rate and lack of any COVID-19 deaths. Claiborne has not challenged this determinative finding on appeal and, thus, has abandoned any claim of error. See United States v. Powell, 666 F.3d 180, 185 & n.4 (4th Cir. 2011). Given that, in order to show an extraordinary and compelling reason for release based upon the COVID-19 pandemic, a prisoner must, among other things, show a particularized risk of contracting COVID-19 at his facility, any error by the district court regarding Claibornes medical condition or the consideration of the § 3553 factors was harmless.
*
Accordingly, we affirm. We dispense with oral argument because the facts and legal contentions are adequately presented in the materials before this court and argument would not aid the decisional process.
AFFIRMED
FOOTNOTES
FOOTNOTE
. Lee USP has vaccinated 190 staff members and 939 inmates. There are currently no COVID-19 cases among inmates, and there have been no deaths. 487 inmates and 159 staff members have recovered. See www.bop.gov/coronavirus/ (last visited Sept. 23, 2021). Given that Lee USPs statistics support the conclusion that COVID-19 is currently contained and that the institution was able to adequately treat those with the virus, we find no reason to overlook Claibornes abandonment of this claim.
PER CURIAM:
Affirmed by unpublished per curiam opinion.
Unpublished opinions are not binding precedent in this circuit.